BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1823185)

  • 1. Myosin light chain kinase autoregulatory pseudosubstrate prototope.
    Pearson RB; Hunt JT; Mitchelhill KI; Kemp BE
    Pept Res; 1991; 4(3):147-53, 156-7. PubMed ID: 1823185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudosubstrate flexibility in chicken smooth muscle myosin light chain kinase.
    Barden JA; Kemp BE
    Biochem Biophys Res Commun; 1996 Jul; 224(3):690-5. PubMed ID: 8713108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the N-terminal region of the skeletal muscle myosin light chain kinase target sequence in its interaction with calmodulin.
    Findlay WA; Gradwell MJ; Bayley PM
    Protein Sci; 1995 Nov; 4(11):2375-82. PubMed ID: 8563635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
    Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
    Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW; Crimmins DL; Thoma RS; Garcia JG
    Arch Biochem Biophys; 1996 Aug; 332(1):101-9. PubMed ID: 8806714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence.
    Kemp BE; Pearson RB; Guerriero V; Bagchi IC; Means AR
    J Biol Chem; 1987 Feb; 262(6):2542-8. PubMed ID: 3818608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutron-scattering studies reveal further details of the Ca2+/calmodulin-dependent activation mechanism of myosin light chain kinase.
    Krueger JK; Zhi G; Stull JT; Trewhella J
    Biochemistry; 1998 Oct; 37(40):13997-4004. PubMed ID: 9760234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent peptide inhibitors of smooth muscle myosin light chain kinase: mapping of the pseudosubstrate and calmodulin binding domains.
    Foster CJ; Johnston SA; Sunday B; Gaeta FC
    Arch Biochem Biophys; 1990 Aug; 280(2):397-404. PubMed ID: 2369131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the pseudosubstrate sequence in smooth muscle myosin light chain kinase thermal stability.
    Faux MC; Pearson RB; Mitchelhill KI; Kemp BE
    J Biol Chem; 1993 Jun; 268(17):12484-91. PubMed ID: 8509388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable conformation and dynamics of calmodulin complexed with peptides derived from the autoinhibitory domains of target proteins.
    Yao Y; Squier TC
    Biochemistry; 1996 May; 35(21):6815-27. PubMed ID: 8639633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin regulation of smooth-muscle myosin light-chain kinase.
    Means AR; George SE
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S25-9. PubMed ID: 2469874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide analog of the calmodulin-binding domain of myosin light chain kinase adopts an alpha-helical structure in aqueous trifluoroethanol.
    Zhang M; Yuan T; Vogel HJ
    Protein Sci; 1993 Nov; 2(11):1931-7. PubMed ID: 8268802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the high affinity and low sequence specificity of calmodulin binding to its targets.
    Afshar M; Caves LS; Guimard L; Hubbard RE; Calas B; Grassy G; Haiech J
    J Mol Biol; 1994 Dec; 244(5):554-71. PubMed ID: 7990140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrasteric regulation of myosin light chain kinase: the pseudosubstrate prototope binds to the active site.
    Bagchi IC; Kemp BE; Means AR
    Mol Endocrinol; 1992 Apr; 6(4):621-6. PubMed ID: 1584224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin kinase II chimeras used to investigate the structural requirements for smooth muscle myosin light chain kinase autoinhibition and calmodulin-dependent activation.
    Chin D; Schreiber JL; Means AR
    Biochemistry; 1999 Nov; 38(46):15061-9. PubMed ID: 10563788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic cleavage sites in smooth muscle myosin-light-chain kinase and their relation to structural and regulatory domains.
    Pearson RB; Ito M; Morrice NA; Smith AJ; Condron R; Wettenhall RE; Kemp BE; Hartshorne DJ
    Eur J Biochem; 1991 Sep; 200(3):723-30. PubMed ID: 1915344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three amino acid substitutions in domain I of calmodulin prevent the activation of chicken smooth muscle myosin light chain kinase.
    VanBerkum MF; Means AR
    J Biol Chem; 1991 Nov; 266(32):21488-95. PubMed ID: 1657969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide analogs of the pseudosubstrate domain of smooth muscle myosin light chain kinase inhibit actomyosin ATPase activity at concentrations that do not inhibit superprecipitation.
    Moreland S; Ikebe M; Hunt JT; Moreland RS
    Biochem Biophys Res Commun; 1992 Sep; 187(3):1279-84. PubMed ID: 1417804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C contains a pseudosubstrate prototope in its regulatory domain.
    House C; Kemp BE
    Science; 1987 Dec; 238(4834):1726-8. PubMed ID: 3686012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of the intrasteric regulation of myosin light chain kinases.
    Knighton DR; Pearson RB; Sowadski JM; Means AR; Ten Eyck LF; Taylor SS; Kemp BE
    Science; 1992 Oct; 258(5079):130-5. PubMed ID: 1439761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.